×
About 232,168 results

ALLMedicine™ Type 2 Diabetes Center

Research & Reviews  110,817 results

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy.
https://doi.org/10.2337/dc20-1402
Diabetes Care; Docherty KF, Jhund PS et. al.

Oct 21st, 2020 - To determine whether the benefits of dapagliflozin in patients with heart failure and reduced ejection fraction (HFrEF) and type 2 diabetes in the Dapagliflozin And Prevention of Adverse-Outcomes in Heart Failure trial (DAPA-HF) varied by backgrou...

Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients.
https://doi.org/10.1038/s41533-020-00207-7
NPJ Primary Care Respiratory Medicine; Ställberg B, Janson C et. al.

Oct 21st, 2020 - This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and th...

A double-edged sword: the association of daytime napping duration and metabolism relate...
https://doi.org/10.1038/s41430-020-00777-2
European Journal of Clinical Nutrition; Zhao X, Cheng L et. al.

Oct 21st, 2020 - Some studies have suggested that daytime napping may increase the risk of type 2 diabetes. However, limited data have revealed the association between nap duration and other metabolic diseases. Data from the baseline survey of Lanxi Cohort Study, ...

The trials and tribulations of determining HbA1c targets for diabetes mellitus.
https://doi.org/10.1038/s41574-020-00425-6
Nature Reviews. Endocrinology; Klein KR, Buse JB

Oct 21st, 2020 - Glycated haemoglobin (HbA1c) is considered the gold standard for predicting glycaemia-associated risks for the microvascular and macrovascular complications of diabetes mellitus over 5-10 years. The value of HbA1c in the care of patients with type...

The Role of Circulating RBP4 in the Type 2 Diabetes Patients with Kidney Diseases: A Sy...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556081
Disease Markers; Zhang L, Cheng YL et. al.

Oct 21st, 2020 - Diabetic nephropathy is a common and serious complication of diabetes mellitus (DM) and is one of the leading causes of end-stage renal disease worldwide. Although there have been many investigations on biomarkers for DN, there is no consistent co...

see more →

Guidelines  373 results

Gestational diabetes, environmental temperature and climate factors - From epidemiologi...
https://doi.org/10.1016/j.earlhumdev.2020.105219
Early Human Development; Pace NP, Vassallo J et. al.

Oct 13th, 2020 - Gestational diabetes (GDM) is a common metabolic complication of pregnancy that is generally asymptomatic in its clinical course, although it is potentially associated with a wide range of both maternal and foetal complications. The population pre...

The interaction between diabetes and climate change - A review on the dual global pheno...
https://doi.org/10.1016/j.earlhumdev.2020.105220
Early Human Development; Cuschieri S, Agius JC

Oct 11th, 2020 - Type 2 diabetes and climate change are forefront global challenges of the 21st century. Both are on a progressive incline with intergenerational effects on the wellbeing, health and security of the population. The aim of this review was to explore...

Guidelines for Pharmacologic Management of Type 2 Diabetes
https://www.jwatch.org/na52380/2020/09/17/guidelines-pharmacologic-management-type-2-diabetes
NEJM Journal Watch;

Sep 16th, 2020 - A recent network meta-analysis of 450 randomized clinical trials demonstrated various benefits of some newer pharmacologic diabetes agents (NEJM JW Gen Med Aug 1 2020 and Ann Intern Med 2020; 173:278). Based on these and other data, the ADA recent...

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545583
Journal of the American College of Cardiology; Das SR, Everett BM et. al.

Aug 10th, 2020 - 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.|2020|Das SR,Everett BM,Birtcher KK,Brown...

Risk of incident type 2 diabetes among patients with rheumatoid arthritis: a population‐based cohort study
https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24343
Arthritis Care & Research; Jin Y

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

see more →

Drugs  2,405 results see all →

Clinicaltrials.gov  114,529 results

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy.
https://doi.org/10.2337/dc20-1402
Diabetes Care; Docherty KF, Jhund PS et. al.

Oct 21st, 2020 - To determine whether the benefits of dapagliflozin in patients with heart failure and reduced ejection fraction (HFrEF) and type 2 diabetes in the Dapagliflozin And Prevention of Adverse-Outcomes in Heart Failure trial (DAPA-HF) varied by backgrou...

Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients.
https://doi.org/10.1038/s41533-020-00207-7
NPJ Primary Care Respiratory Medicine; Ställberg B, Janson C et. al.

Oct 21st, 2020 - This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and th...

A double-edged sword: the association of daytime napping duration and metabolism relate...
https://doi.org/10.1038/s41430-020-00777-2
European Journal of Clinical Nutrition; Zhao X, Cheng L et. al.

Oct 21st, 2020 - Some studies have suggested that daytime napping may increase the risk of type 2 diabetes. However, limited data have revealed the association between nap duration and other metabolic diseases. Data from the baseline survey of Lanxi Cohort Study, ...

The trials and tribulations of determining HbA1c targets for diabetes mellitus.
https://doi.org/10.1038/s41574-020-00425-6
Nature Reviews. Endocrinology; Klein KR, Buse JB

Oct 21st, 2020 - Glycated haemoglobin (HbA1c) is considered the gold standard for predicting glycaemia-associated risks for the microvascular and macrovascular complications of diabetes mellitus over 5-10 years. The value of HbA1c in the care of patients with type...

The Role of Circulating RBP4 in the Type 2 Diabetes Patients with Kidney Diseases: A Sy...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556081
Disease Markers; Zhang L, Cheng YL et. al.

Oct 21st, 2020 - Diabetic nephropathy is a common and serious complication of diabetes mellitus (DM) and is one of the leading causes of end-stage renal disease worldwide. Although there have been many investigations on biomarkers for DN, there is no consistent co...

see more →

News  3,961 results

Guidelines for Pharmacologic Management of Type 2 Diabetes
https://www.jwatch.org/na52380/2020/09/17/guidelines-pharmacologic-management-type-2-diabetes
NEJM Journal Watch;

Sep 16th, 2020 - A recent network meta-analysis of 450 randomized clinical trials demonstrated various benefits of some newer pharmacologic diabetes agents (NEJM JW Gen Med Aug 1 2020 and Ann Intern Med 2020; 173:278). Based on these and other data, the ADA recent...

Risk of incident type 2 diabetes among patients with rheumatoid arthritis: a population‐based cohort study
https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24343
Arthritis Care & Research; Jin Y

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

Low fitness level linked to higher risk of heart failure in diabetes
https://www.mdedge.com/endocrinology/article/219455/heart-failure/low-fitness-level-linked-higher-risk-heart-failure?channel=39313
Doug Brunk

Mar 23rd, 2020 - PHOENIX – Lower baseline fitness and greater decline in fitness over time are independently associated with a higher risk of heart failure in patients with diabetes, results from a large analysis showed. Doug Brunk/MDedge News Dr.

FDA advises stopping SGLT2 inhibitor treatment prior to surgery
https://www.mdedge.com/jcomjournal/article/219251/diabetes/fda-advises-stopping-sglt2-inhibitor-treatment-prior-surgery?channel=302
Lucas Franki

Mar 18th, 2020 - The Food and Drug Administration has approved safety labeling changes to all sodium-glucose transporter 2 (SGLT2) inhibitors used to treat high blood sugar in patients with type 2 diabetes. The new changes affect canagliflozin, dapagliflozin, empa.

Study links GLP-1R agonists, lower inflammatory biomarker levels
https://www.mdedge.com/pulmonary-health-hub/article/219245/asthma/study-links-glp-1r-agonists-lower-inflammatory-biomarker?channel=94
Richard Mark Kirkner

Mar 18th, 2020 - Patients with both type 2 diabetes and asthma who were on glucagonlike peptide receptor–1 (GLP-1R) agonists for glucose control had lower levels of a key biomarker of airway inflammation than similar patients on other types of glucose-control medi.

see more →

Patient Education  83 results see all →